Vanguard Group’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-13,097,546
Closed -$79M 4133
2019
Q4
$79M Buy
13,097,546
+831,697
+7% +$5.02M ﹤0.01% 1890
2019
Q3
$44.2M Buy
12,265,849
+8,296
+0.1% +$29.9K ﹤0.01% 2125
2019
Q2
$32.9M Buy
12,257,553
+324,147
+3% +$869K ﹤0.01% 2299
2019
Q1
$35.3M Buy
11,933,406
+3,315,881
+38% +$9.82M ﹤0.01% 2257
2018
Q4
$13.7M Sell
8,617,525
-3,096,015
-26% -$4.92M ﹤0.01% 2613
2018
Q3
$43.1M Buy
11,713,540
+601,486
+5% +$2.21M ﹤0.01% 2216
2018
Q2
$31.4M Buy
11,112,054
+254,241
+2% +$720K ﹤0.01% 2360
2018
Q1
$40.3M Buy
10,857,813
+48,818
+0.5% +$181K ﹤0.01% 2182
2017
Q4
$31.1M Buy
10,808,995
+1,391,152
+15% +$4.01M ﹤0.01% 2304
2017
Q3
$42.3M Sell
9,417,843
-156,492
-2% -$703K ﹤0.01% 2119
2017
Q2
$43.9M Sell
9,574,335
-11,488
-0.1% -$52.7K ﹤0.01% 2070
2017
Q1
$40.4M Buy
9,585,823
+646,415
+7% +$2.72M ﹤0.01% 2108
2016
Q4
$36.9M Buy
8,939,408
+274,451
+3% +$1.13M ﹤0.01% 2125
2016
Q3
$70.2M Buy
8,664,957
+210,244
+2% +$1.7M ﹤0.01% 1773
2016
Q2
$65.9M Buy
8,454,713
+455,251
+6% +$3.55M ﹤0.01% 1773
2016
Q1
$61.8M Buy
7,999,462
+316,841
+4% +$2.45M ﹤0.01% 1764
2015
Q4
$82.9M Buy
7,682,621
+311,482
+4% +$3.36M 0.01% 1587
2015
Q3
$50.9M Buy
7,371,139
+482,122
+7% +$3.33M ﹤0.01% 1859
2015
Q2
$61M Buy
6,889,017
+418,588
+6% +$3.71M ﹤0.01% 1828
2015
Q1
$63.8M Buy
6,470,429
+984,408
+18% +$9.71M ﹤0.01% 1795
2014
Q4
$67.2M Buy
5,486,021
+488,206
+10% +$5.98M ﹤0.01% 1682
2014
Q3
$49.9M Buy
4,997,815
+107,821
+2% +$1.08M ﹤0.01% 1790
2014
Q2
$37M Sell
4,889,994
-228,932
-4% -$1.73M ﹤0.01% 1979
2014
Q1
$16.8M Buy
5,118,926
+428,383
+9% +$1.41M ﹤0.01% 2252
2013
Q4
$15.6M Buy
4,690,543
+363,388
+8% +$1.21M ﹤0.01% 2262
2013
Q3
$13.1M Buy
4,327,155
+148,402
+4% +$448K ﹤0.01% 2277
2013
Q2
$34.2M Buy
+4,178,753
New +$34.2M ﹤0.01% 1858